Daclatasvir Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Daclatasvir is used along with another medication (sofosbuvir [Solvadi]) to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors.Daclatasvir Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Daclatasvir Nitroso CAS NO:NA chemically represented as Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1-nitroso-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate. Synchemia is the leading manufacturing and exporter of Daclatasvir Nitroso . We supply Daclatasvir Nitroso with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142419 |
| CAS No | NA |
| Mol.F. | C14H15N3O |
| Mol.Wt. | 241.29 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142420 |
| CAS No | NA |
| Mol.F. | C17H20N2O2 |
| Mol.Wt. | 284.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142421 |
| CAS No | NA |
| Mol.F. | C16H18N2O2 : C2H2O4 |
| Mol.Wt. | 270.3 : 90.0 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142422 |
| CAS No | NA |
| Mol.F. | C17H20N2O2 |
| Mol.Wt. | 284.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142423 |
| CAS No | NA |
| Mol.F. | C17H20N2O2 |
| Mol.Wt. | 284.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142424 |
| CAS No | NA |
| Mol.F. | C17H19FN2O2 |
| Mol.Wt. | 302.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142425 |
| CAS No | NA |
| Mol.F. | C27H33N3O3 |
| Mol.Wt. | 447.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142426 |
| CAS No | NA |
| Mol.F. | C27H32N4O4 |
| Mol.Wt. | 476.58 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142427 |
| CAS No | NA |
| Mol.F. | C10H14N2O2 |
| Mol.Wt. | 194.23 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142428 |
| CAS No | NA |
| Mol.F. | C8H13ClN6O |
| Mol.Wt. | 244.68 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142429 |
| CAS No | NA |
| Mol.F. | C8H12ClN7O2 |
| Mol.Wt. | 273.68 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142430 |
| CAS No | NA |
| Mol.F. | C7H11ClN6O |
| Mol.Wt. | 230.66 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142431 |
| CAS No | NA |
| Mol.F. | C16H18N2O4 |
| Mol.Wt. | 302.33 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142432 |
| CAS No | NA |
| Mol.F. | C25H36N2O5 |
| Mol.Wt. | 444.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142433 |
| CAS No | NA |
| Mol.F. | C11H16N2O3 |
| Mol.Wt. | 224.26 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142434 |
| CAS No | NA |
| Mol.F. | C16H18N2O2 |
| Mol.Wt. | 270.33 g/mol |
| INV STATUS | In Stock |